Detalhe da pesquisa
1.
Unlocking the therapeutic potential of primary tumor-draining lymph nodes.
Cancer Immunol Immunother
; 68(10): 1681-1688, 2019 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-30944963
2.
Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.
Cancer Immunol Immunother
; 68(6): 1037, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30919028
3.
Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.
Cancer Immunol Immunother
; 68(6): 1025-1035, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30852622
4.
Recent developments and future challenges in immune checkpoint inhibitory cancer treatment.
Curr Opin Oncol
; 27(6): 482-8, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26352539
5.
Local delivery of low-dose anti-CTLA-4 to the melanoma lymphatic basin leads to systemic Treg reduction and effector T cell activation.
Sci Immunol
; 7(73): eabn8097, 2022 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35857579
6.
T cell infiltration on local CpG-B delivery in early-stage melanoma is predominantly related to CLEC9A+CD141+ cDC1 and CD14+ antigen-presenting cell recruitment.
J Immunother Cancer
; 9(3)2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33737341
7.
In the mix: the potential benefits of adding GM-CSF to CpG-B in the local treatment of patients with early-stage melanoma.
Oncoimmunology
; 9(1): 1708066, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32002303
8.
Melanoma Sequentially Suppresses Different DC Subsets in the Sentinel Lymph Node, Affecting Disease Spread and Recurrence.
Cancer Immunol Res
; 5(11): 969-977, 2017 11.
Artigo
Inglês
| MEDLINE | ID: mdl-28935649
9.
Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I-II Melanoma: Data from Two Randomized Phase II Trials.
Clin Cancer Res
; 23(19): 5679-5686, 2017 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28972083
10.
High and interrelated rates of PD-L1+CD14+ antigen-presenting cells and regulatory T cells mark the microenvironment of metastatic lymph nodes from patients with cervical cancer.
Cancer Immunol Res
; 3(1): 48-58, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25361854
11.
Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141(+) Dendritic Cells and Enhanced Cross-Presentation.
Cancer Immunol Res
; 3(5): 495-505, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25633713